CSIMarket Company Name, Ticker, Competitors, else..
 
Can B Corp   (CANB)
Other Ticker:  
 
 
Price: $0.0525 $-0.01 -19.355%
Day's High: $0.075 Week Perf: -4.55 %
Day's Low: $ 0.05 30 Day Perf: 31.25 %
Volume (M): 44 52 Wk High: $ 1.75
Volume (M$): $ 2 52 Wk Avg: $0.53
Open: $0.07 52 Wk Low: $0.03



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 6
 Employees -
 Revenues (TTM) (Millions $) 5
 Net Income (TTM) (Millions $) -14
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Can B Corp
The Company operates several divisions, including document management and email marketing platforms; however, its primary operations are from the development and sale of products containing CBD. The Company’s products contain CBD derived from Hemp and include products such as oils, creams, moisturizers, chews, vapes, isolate, gel caps, concentrate and water. In addition to offering white labeled products, Canbiola is developing its own line of proprietary products, as well as seeking synergistic value through acquisitions in the Hemp industry. Canbiola aims to be the premier provider of the highest quality natural Hemp CBD products on the market through sourcing the very best raw material and developing a variety of products we believe will improve peoples lives in a variety of areas.


   Company Address: 960 South Broadway Hicksville 11801 NY
   Company Phone Number: 595-9544   Stock Exchange / Ticker: CANB
   CANB is expected to report next financial results on April 16, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Stemtech Corporation

Outstanding attainment by STEK in the fiscal three months ending September 30 2023

the Pharmacy Services and Retail Drugstore company announced in the July to September 30 2023 surge in revenue by 26.426 % to $1.30 million from the corresponding financial reporting period a year prior, but it has posted a shortfall per stock at $-0.01 per share. STEKs' business rose at higher rate compared to the the revenue at virtually all of the Pharmacy Services and Retail Drugstore sector contemporaries, in the third quarter of 2023 the majority companies in Pharmacy Services and Retail Drugstore industries saw the business advance of 9.85% relative to the corresponding period a year ago.

Bimi International Medical Inc

Bimi International Medical Inc Continues to Surge with Record Revenue of $5.5 Million in Q2 2023

Bimi International Medical Inc, a renowned medical company, has recently announced its impressive financial results for the fiscal period ending on June 30, 2023. The company generated a substantial revenue of $5.557666 million, which indicates a significant growth in its operations. Moreover, Bimi International Medical Inc also exhibited an improving profit margin, with a net margin of 18.97% and an operating margin of 23.38%.
One notable aspect of their financial statement is the decline in net earnings compared to the corresponding period the previous year. While Bimi International Medical Inc recorded no profits in the previous period, the company experienced a decline in net earnings, which amounted to $1.054 million in the current period. Although this decline might seem alarming at first, the company's overall performance and the growth in revenue indicate that Bimi International Medical Inc is still on a positive trajectory.
Cosmos Health Inc

Cosmos Health Inc. Demonstrates Impressive Revenue Growth in Q3 2023 Despite Minor Deficit



Cosmos Health Inc, a company trading on the NASDAQ, has experienced a decline in share prices over the past month, along with a significant drop compared to its 52-week average. However, recent positive developments have been observed, including an increase in COSM shares over the last five trading days. These contrasting trends and the third-quarter financial results indicate some challenges for Cosmos Health Inc, which may have ramifications for the company's future prospects.
1. Share Performance:
- Cosmos Health Inc shares have witnessed a decline of -2.7% over the past 30 days, suggesting a loss of investor confidence.
- COSM shares, on the other hand, have shown growth of 3.85% over the last five trading days, implying a short-term recovery for the company.
Trees Corporation

Trees Corporation Boasts Remarkable 29.41% Surge in Revenue for Q3 2023, Shining in the Pharmacy Services and Retail Drugstore Industry

Financial News Report: Trees Corporation Reports Improved Earnings and Revenue Growth in Q3 2023
Trees Corporation, a leading Pharmacy Services and Retail Drugstore company, recently announced its financial results for the third quarter of 2023. The company showed significant improvements in earnings per share (EPS) and revenue growth compared to the same period in the previous year.
During the third quarter of 2023 earnings season, Trees Corporation reported a decrease in loss per share of $0.01, compared to a loss of $0.03 per share in the same period a year before. This represents a positive development for the company and demonstrates its efforts to reduce losses. Additionally, the EPS improved from -$0.02 in the preceding financial reporting period.
Petiq Inc

Astonishing Financial Rebound: PetIQ Inc. Transforms Losses into Gains, Embarks on a Path of Success

the third quarter financial results of PetIQ Inc. (NASDAQ: PETQ), a prominent pet medication and wellness company, have been released, investors are provided with substantial evidence of the company's improving financial health. According to the report for the July to September 30, 2023, time-frame, PetIQ Inc. has achieved remarkable improvements in various financial indicators.
First and foremost, the company's earnings turned positive in this period, with a significant increase from a loss of $-1.68 per share to a gain of $0.02 per share compared to the same period last year. This represents a remarkable recovery and reflects the successful implementation of the company's strategic initiatives.





 

Can B's Segments
 
 
• View Complete Report




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com